DrugSupplement
Viscum album peptide clinical trials
Also written mistletoe extract.
- studies test it
- 10
- open now
- 0
- in phase 3
- 3
- first study started
- 2000
How studies write it
Studies that test it under each name
Other names
Studies by the year they started
10 studies that test it; most in 2000 (2)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
Abnoba Gmbh (3) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Karolinska University Hospital (1) · Abnoba Korea (1) · Rambam Health Care Campus (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Sidney Kimmel Cancer Center at Thomas Jefferson University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses viscum album peptide is read from its arms, and is right about nine times in ten.
Testing it · 10
- Therapeutic Instillation of MistletoeTerminatedPhase 3Abnoba GmbhNCT02106572Written as abnobaVISCUM 900
- Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic CancerCompletedPhase 3Karolinska University HospitalNCT02948309Written as Mistletoe extract (Iscador Qu)
- Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder CancerCompletedPhase 1/2Abnoba GmbhNCT02007005Written as abnobaVISCUM Fraxini
- Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion PatientsCompletedPhase 3Abnoba KoreaNCT02191540Written as Abnoba Viscum F 20mg
- Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyStatus unknownPhase 2Sidney Kimmel Cancer Center at Thomas Jefferson UniversityNCT00052325Written as mistletoe extract
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedPhase 1National Center for Complementary and Integrative Health (NCCIH)NCT00049608Written as mistletoe extract
- RCT With Adjuvant Mistletoe Treatment in Gastric Cancer PatientsCompletedPhase 4Abnoba GmbhNCT01401075Written as mistletoe extract
- Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedPhase 1European Organisation for Research and Treatment of Cancer - EORTCNCT00006354Written as mistletoe extract
- Mistletoe Lectin in Treating Patients With Refractory Advanced Solid TumorsCompletedPhase 1European Organisation for Research and Treatment of Cancer - EORTCNCT00006477Written as mistletoe extract
- Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.CompletedPhase 2Rambam Health Care CampusNCT00516022Written as Mistletoe extract
Codes
What other systems call viscum album peptide · ClinicalTrials.gg INT003669
- MeSH (NLM) C077177viscum album peptideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) BK9092J5MPVISCUM ALBUM FRUITING TOPConfirmed FDA, NLM
- RxNorm 1310003One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C077177 | viscum album peptide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | BK9092J5MP | VISCUM ALBUM FRUITING TOP | Confirmed FDA, NLM |
| RxNorm | 1310003 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.